Point72 Asset Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.3M | Sell |
4,911,924
-383,621
| -7% | -$2.75M | 0.07% | 288 |
|
|
2025
Q1 | $31.7M | Sell |
5,295,545
-51,757
| -1% | -$310K | 0.07% | 286 |
|
|
2024
Q4 | $41.7M | Sell |
5,347,302
-5,123,096
| -49% | -$40M | 0.09% | 239 |
|
|
2024
Q3 | $113M | Hold |
10,470,398
| – | – | 0.29% | 67 |
|
|
2024
Q2 | $88.3M | Buy |
10,470,398
+3,794,150
| +57% | +$32M | 0.23% | 109 |
|
|
2024
Q1 | $44.9M | Buy |
6,676,248
+1,484,800
| +29% | +$9.98M | 0.11% | 214 |
|
|
2023
Q4 | $30.5M | Buy |
5,191,448
+1,424,693
| +38% | +$8.38M | 0.07% | 293 |
|
|
2023
Q3 | $36.7M | Sell |
3,766,755
-918,299
| -20% | -$8.95M | 0.11% | 226 |
|
|
2023
Q2 | $55.5M | Buy |
4,685,054
+2,448,354
| +109% | +$29M | 0.17% | 153 |
|
|
2023
Q1 | $24.1M | Buy |
+2,236,700
| New | +$24.1M | 0.07% | 277 |
|
|
2022
Q4 | – | Sell |
-357,200
| Closed | -$5.33M | – | 1136 |
|
|
2022
Q3 | $5.33M | Buy |
+357,200
| New | +$5.33M | 0.02% | 621 |
|
|
2022
Q2 | – | Sell |
-853,451
| Closed | -$6.39M | – | 1084 |
|
|
2022
Q1 | $6.39M | Sell |
853,451
-13,449
| -2% | -$101K | 0.03% | 579 |
|
|
2021
Q4 | $7.44M | Sell |
866,900
-138,403
| -14% | -$1.19M | 0.03% | 557 |
|
|
2021
Q3 | $8.46M | Sell |
1,005,303
-477,792
| -32% | -$4.02M | 0.04% | 498 |
|
|
2021
Q2 | $12M | Buy |
1,483,095
+871,595
| +143% | +$7.07M | 0.05% | 382 |
|
|
2021
Q1 | $5.37M | Buy |
611,500
+206,500
| +51% | +$1.81M | 0.03% | 523 |
|
|
2020
Q4 | $4.55M | Buy |
+405,000
| New | +$4.55M | 0.02% | 564 |
|
|
2018
Q3 | – | Sell |
-150,000
| Closed | -$2.15M | – | 874 |
|
|
2018
Q2 | $2.15M | Sell |
150,000
-173,900
| -54% | -$2.5M | 0.01% | 591 |
|
|
2018
Q1 | $3.6M | Buy |
+323,900
| New | +$3.6M | 0.02% | 515 |
|